T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1214-1220

  Kido, M ^a   Takeuchi, S ^a   Sugiyama, N ^a   Esaki, H ^a   Nakashima, H ^b   Yoshida, H ^c   Furue, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 27; INTERLEUKIN 4; PROTEIN WSX 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DERMIS; DISEASE SEVERITY; EPIDERMIS; GENE; GENE DISRUPTION; GENE OVEREXPRESSION; INFLAMMATORY CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH2 CELL; WSX 1 GENE;

ANIMALS; DERMATITIS; IMMUNOGLOBULIN G; INTERLEUKIN-17; MAST CELLS; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS;

EID: 79957596746     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10244.x     Document Type: Article

References (24)

1. Vyse TJ, Kotzin BL,. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998; 16: 261-92. (Pubitemid 28183366)
2. Furukawa F, Tanaka H, Sekita K, et al. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 1984; 276: 186-94. (Pubitemid 14107771)
3. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-17.
4. Furukawa F, Yoshimasu T,. Animal models of spontaneous and drug-induced cutaneous lupus erythematosus. Autoimmun Rev 2005; 4: 345-50. (Pubitemid 41080071)
5. Ghoreishi M, Dutz JP,. Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev 2009; 8: 484-7.
6. Yoshida H, Miyazaki Y,. Regulation of immune responses by interleukin-27. Immunol Rev 2008; 226: 234-47.
7. Yoshida H, Hamano S, Senaldi G, et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001; 15: 569-78. (Pubitemid 33016442)
8. Stumhofer JS, Hunter CA,. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008; 117: 123-30.
9. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 (+) T cells. Immunity 2002; 16: 779-90. (Pubitemid 34786477)
10. Shimizu S, Sugiyama N, Masutani K, et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 2005; 175: 7185-92. (Pubitemid 41713412)
11. Sugiyama N, Nakashima H, Yoshimura T, et al. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of IL-27R{alpha} (WSX-1). Ann Rheum Dis 2007; 67: 1461-7.
12. Hashimoto Y, Arai I, Takano N, et al. Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis. Br J Dermatol 2006; 154: 28-33. (Pubitemid 43381316)
13. Nalbandian A, Crispín JC, Tsokos GC,. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009; 157: 209-15.
14. Weiss E, Mamelak AJ, La Morgia S, et al. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. J Am Acad Dermatol 2004; 50: 657-75.
15. Li TT, Zhang T, Chen GM, et al. Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med 2010; 58: 737-9.
16. Peng SL, Moslehi J, Craft J,. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997; 99: 1936-46. (Pubitemid 27175941)
17. Holdsworth SR, Kitching AR, Tipping PG,. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 1999; 55: 1198-216. (Pubitemid 29157116)
18. Stein LF, Saed GM, Fivenson DP,. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol 1997; 36: 191-6. (Pubitemid 27078910)
19. Wenzel J, Wörenkämper E, Freutel S, et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005; 205: 435-42. (Pubitemid 40361331)
20. Elenitsas R, Abell E, Lee YY, et al. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus. J Dermatol Sci 1990; 1: 207-15.
21. Alahlafi AM, Wordsworth P, Wojnarowska F,. The distribution of IgG subclasses in the lupus band suggests disease-specific alteration in subclass switching rather than polyclonal B-cell activation. Clin Exp Dermatol 2004; 29: 288-92. (Pubitemid 38658473)
22. Provost TT, Reichlin M,. Immunopathologic studies of cutaneous lupus erythematosus. J Clin Immunol 1988; 8: 223-33.
23. Krishnaswamy G, Kelley J, Johnson D, et al. The human mast cell: functions in physiology and disease. Front Biosci 2001; 6: D1109-27.
24. Maezawa Y, Nakajima H, Kumano K, et al. Role of IgE in Th2 cell-mediated allergic airway inflammation. Int Arch Allergy Immunol 2003; 131 (Suppl. 1): 2-6. (Pubitemid 36677052)